ArticleCase reports in infectious diseases2026
Chorioamnionitis in the Second Trimester Secondary to Multidrug-Resistant
Article in Case reports in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chorioamnionitis in the Second Trimester Secondary to Multidrug-ResistantCase reports in infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Nontypeable Methods: A 22-year-old woman at 22 weeks 3 days' gestation presented with preterm prelabor rupture of membranes (PPROM) and vaginal bleeding. Evaluation included cervical examination and bedside ultrasound. Placental tissue was collected for culture and antimicrobial susceptibility testing. The hospital course, clinical interventions, and postpartum outcomes were recorded. A literature review of reported cases was conducted to contextualize the findings and inform management strategies. Results: On admission, cervical dilation was 3 cm, and fetal heart tones were present. Ultrasound demonstrated anhydramnios. Maternal inflammatory markers were elevated, consistent with chorioamnionitis. Despite the use of antibiotics, spontaneous vaginal delivery occurred at 22 weeks 3 days, complicated by cord avulsion and manual placental extraction. Placental cultures grew NTHi resistant to ampicillin and amoxicillin-clavulanate but susceptible to ceftriaxone, azithromycin, and ciprofloxacin. Postpartum complications included retained products of conception requiring dilation and curettage. Reported cases similarly support ascending genital tract infection as the most likely source and demonstrate increasing antimicrobial resistance in pregnancy-associated isolates. Conclusion: NTHi represents an uncommon yet clinically important cause of second-trimester chorioamnionitis and early pregnancy loss. Clinicians should consider NTHi in cases of intrauterine infection when standard pathogens are not identified or when empiric antibiotic therapy fails. Early recognition, comprehensive microbiologic evaluation, and antibiotic selection guided by susceptibility patterns are essential to optimize maternal and fetal outcomes. Rising antimicrobial resistance among NTHi strains underscores the need for continued surveillance and evidence-based management strategies in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.